Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07268404 · ClinicalTrials.gov registry record · NA
Women's Hormonal and Metabolic Wellbeing Study
A NA study of Metabolic Health, sponsored by Daily Nouri.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07268404: Recruiting NA study of Metabolic Health, sponsored by Daily Nouri.
NCT07268404 is a NA study of Metabolic Health that is actively recruiting participants, run by Daily Nouri. The registered enrollment target is 60 participants, below the 50,139-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07268404, a NA study of Metabolic Health, is actively recruiting participants, sponsored by Daily Nouri.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if Daily Nouri Hormone Balance Probiotic blend can improve metabolic, inflammatory, and symptom outcomes in women. Participants will: * Take the probiotic blend or placebo every day for 12 weeks * Complete virtual assessments and report symptoms throughout the study
Primary Outcome
Women's Health Quality of Life as measured by changes in total and domains scores on the Health-Related Quality of Life Questionnaire for Polycystic Ovary Syndrome-26 (PCOSQ-26). Response Scale: 7-Point Likert Scale Per-Item Range: minimum: 1, maximum: 7, where higher scores indicate better outcomes.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Probiotic Blend Capsule
Study Locations (1)
California
- Alethios, Inc. - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-12 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07268404 shows while recruiting
NCT07268404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 50,139-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Metabolic Health appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07268404 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07268404 about?
NCT07268404 is a clinical study titled "Women's Hormonal and Metabolic Wellbeing Study". The goal of this clinical trial is to learn if Daily Nouri Hormone Balance Probiotic blend can improve metabolic, inflammatory, and symptom outcomes in women. Participants will: * Take the probiotic blend or placebo every day for 12 weeks * Complete virtual assessments and report symptoms througho...
What is the current status of trial NCT07268404?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-12. Estimated completion is 2026-12.
What conditions does trial NCT07268404 study?
This clinical trial studies the following conditions: Metabolic Health.
What interventions are being tested in trial NCT07268404?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic Blend Capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07268404?
This trial is sponsored by Daily Nouri, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07268404 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07268404's enrollment target sits among peer trials
60 6th of 10 higher than 3 of 10 other Metabolic Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions
RECRUITING · NA
-
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
RECRUITING · NA
-
Study to Evaluate the Efficacy of an Avocado Dietary Supplement
ACTIVE NOT RECRUITING · NA
-
Impact of Protein Source and Polyphenol Complexation in Protein Bars on Metabolic Health
ACTIVE NOT RECRUITING · NA
-
Effects of a Synbiotic Supplement on Metabolic & Cognitive Outcomes Among Older Adults
COMPLETED · NA
-
Metabolic Health 1: Power Line Evaluation; Effect Size Determination
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia